Log In
Print
BCIQ
Print
Print this Print this
 

EBI-005

  Manage Alerts
Collapse Summary General Information
Company Eleven Biotherapeutics Inc.
DescriptionIL-1 receptor antagonist
Molecular Target Interleukin-1 (IL-1)
Mechanism of ActionInterleukin-1 (IL-1) receptor antagonist
Therapeutic ModalityBiologic: Protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today